The effectiveness of the 2012/13 trivalent seasonal influenza vaccine (TIV) was assessed using a test-negative case-control study of patients consulting primary care with influenza-like illness in the United Kingdom. Strain characterisation was undertaken on selected isolates. Vaccine effectiveness (VE) against confirmed influenza A(H3N2), A(H1N1) and B virus infection, adjusted for age, sex, s...

Newcastle Disease is still endemic in Pakistan’s poultry industry and responsible for great economic losses and high mortalities. Avian Influenza Virus has been involved in production losses in past few years, with or without the association of Newcastle Disease in the field. Therefore, present study was planned to evaluate the cross protection between Avian Influenza Virus and Newcastle Diseas...

OBJECTIVE Annually, influenza epidemics are associated with high mortality rates, notably among elderly persons. The aim of the study was to examine the level of influenza vaccine coverage among Chinese residents aged 60 years and older and to examine the demographic, behavioural and lifestyle health factors associated with vaccine receipt. DESIGN Cross-sectional study. SETTING Beijing, Chi...

INTRODUCTION Emerging data suggest that receipt of the seasonal influenza vaccine may be associated with an enhanced risk of infection with pandemic (H1N1) 2009 (pH1N1). We sought to evaluate different seasonal vaccination strategies during a pandemic in the presence of varying levels of pH1N1 infection risk following seasonal influenza vaccine receipt. METHODS We developed a deterministic, a...

We evaluated the effectiveness of the 2010-2011 seasonal influenza vaccine for preventing laboratory-confirmed influenza in a South Korean population. A retrospective case-control study was conducted among patients who visited selected hospitals from September 2010 to May 2011. A total of 483 laboratory-confirmed influenza patients were included in the analysis as case subjects. For each case p...

Vaccination against seasonal influenza viruses is the most effective way to prevent infection. A key factor in the effectiveness of the seasonal influenza vaccine is its immunological compatibility with the circulating viruses during the season. The high evolutionary rate, antigenic shift and antigenic drift of influenza viruses, represents the main obstacle for correct prediction of the vaccin...

THE DRASTICALLY DECREASED SUPPLY OF INACTIVATED influenza vaccine for the 2004-2005 US influenza season presents a unique challenge for health care institutions. At the core of this challenge is the dual responsibility that health care institutions have to protect patients as well as the health professionals who are integral to the functioning of the institution. Many major hospitals and long-t...

OBJECTIVES The goal of this double-blind, randomized, controlled clinical trial was to assess the safety and immunogenicity of two different doses of a monovalent split-virion 2009 pandemic influenza A/H1N1 vaccine without adjuvant in Chinese infants aged 6-35 months. DESIGN AND SETTING  Subjects were randomly assigned to receive either a 2009 pandemic (H1N1) vaccine containing 7.5 or 15 μg hae...

OBJECTIVE During the 2000 to 2001 influenza season, distribution of influenza vaccine was delayed, and national self-reported vaccination rates declined. The purposes of this study were to characterize missed opportunities for adult vaccinations and assess the impact of the vaccine delay on missed opportunities for influenza vaccination as recorded in medical records. METHODS In a cross-secti...

BACKGROUND To improve influenza vaccination coverage in the working age population, it is necessary to understand the current status and awareness of influenza vaccination. This study aimed to determine influenza vaccination coverage in Japan and reasons for receiving the vaccine or not. METHODS An anonymous internet-based survey was performed in September 2011. Our target study size was 3,00...